- Home
- IMNN vs AMS Comparison
IMNN vs AMS Comparison
Compare IMNN & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNN | AMS |
|---|---|---|
| Founded | 1982 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 14.2M |
| IPO Year | 1985 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNN | AMS |
|---|---|---|
| Price | $3.25 | $2.25 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $182.61 | N/A |
| AVG Volume (30 Days) | ★ 36.3K | 9.4K |
| Earning Date | 03-27-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $29,423,000.00 |
| Revenue This Year | N/A | $3.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.84 |
| 52 Week Low | $2.99 | $2.01 |
| 52 Week High | $41.22 | $3.11 |
Technical Indicators
Market Signals| Indicator | IMNN | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 42.61 | 60.83 |
| Support Level | $3.03 | $2.09 |
| Resistance Level | $3.62 | $2.39 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 25.57 | 54.82 |
Price Performance
Historical ComparisonAbout IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.